rs139992251
Positions:
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2
The NM_020435.4(GJC2):c.147C>T(p.Asp49Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000743 in 1,612,666 control chromosomes in the GnomAD database, including 12 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.00093 ( 2 hom., cov: 32)
Exomes 𝑓: 0.00072 ( 10 hom. )
Consequence
GJC2
NM_020435.4 synonymous
NM_020435.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.169
Genes affected
GJC2 (HGNC:17494): (gap junction protein gamma 2) This gene encodes a gap junction protein. Gap junction proteins are members of a large family of homologous connexins and comprise 4 transmembrane, 2 extracellular, and 3 cytoplasmic domains. This gene plays a key role in central myelination and is involved in peripheral myelination in humans. Defects in this gene are the cause of autosomal recessive Pelizaeus-Merzbacher-like disease-1. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.38).
BP6
Variant 1-228157905-C-T is Benign according to our data. Variant chr1-228157905-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 261256.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-228157905-C-T is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=-0.169 with no splicing effect.
BS1
Variant frequency is greater than expected in population eas. gnomad4 allele frequency = 0.000932 (142/152282) while in subpopulation EAS AF= 0.0149 (77/5176). AF 95% confidence interval is 0.0122. There are 2 homozygotes in gnomad4. There are 86 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 2 AD,AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GJC2 | NM_020435.4 | c.147C>T | p.Asp49Asp | synonymous_variant | 2/2 | ENST00000366714.3 | NP_065168.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GJC2 | ENST00000366714.3 | c.147C>T | p.Asp49Asp | synonymous_variant | 2/2 | 1 | NM_020435.4 | ENSP00000355675.2 |
Frequencies
GnomAD3 genomes AF: 0.000920 AC: 140AN: 152176Hom.: 1 Cov.: 32
GnomAD3 genomes
AF:
AC:
140
AN:
152176
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00183 AC: 452AN: 247580Hom.: 4 AF XY: 0.00182 AC XY: 245AN XY: 134726
GnomAD3 exomes
AF:
AC:
452
AN:
247580
Hom.:
AF XY:
AC XY:
245
AN XY:
134726
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000723 AC: 1056AN: 1460384Hom.: 10 Cov.: 37 AF XY: 0.000757 AC XY: 550AN XY: 726488
GnomAD4 exome
AF:
AC:
1056
AN:
1460384
Hom.:
Cov.:
37
AF XY:
AC XY:
550
AN XY:
726488
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000932 AC: 142AN: 152282Hom.: 2 Cov.: 32 AF XY: 0.00116 AC XY: 86AN XY: 74450
GnomAD4 genome
AF:
AC:
142
AN:
152282
Hom.:
Cov.:
32
AF XY:
AC XY:
86
AN XY:
74450
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
39
AN:
3454
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Spastic paraplegia Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 11, 2023 | - - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at